Skip to main content
logo
UroGen Pharma Ltd. (URGN)
NASDAQ: URGN · Real-Time Price · USD
46.96
+1.36 (2.98%)
At close: Aug 7, 2026, 4:00 PM EDT
47.12
+0.16 (0.34%)
After-hours: Aug 7, 2026, 7:55 PM EDT

UroGen Pharma Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-97.64-153.49-126.87-102.24-109.78-110.82
Depreciation & Amortization
2.642.411.191.711.821.77
Stock-Based Compensation
16.1211.9613.119.3410.5823.11
Other Adjustments
5.194.5910.8811.4816.1315.32
Change in Receivables
-69.11-12.78-4.86-2.74-0.99-4.67
Changes in Inventories
-17.46-7.24-3.55-1.35-0.36-2.87
Changes in Accounts Payable
8.980.2910.894.160.282
Changes in Accrued Expenses
0.612.95-0.242.561.31-2.61
Changes in Income Taxes Payable
-0.110.60.180.180.13
Changes in Other Operating Activities
-8.35-11.242.10.54-6.72-6.26
Operating Cash Flow
-158.92-162.44-96.77-76.38-87.56-84.89
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.22-0.29-0.3-0.19-0.25-0.75
Purchases of Investments
-34.04-77.4-128.02-49.83-63.01-51.9
Proceeds from Sale of Investments
74.36139.25107.7149.0764.3256.72
Investing Cash Flow
40.161.56-20.61-0.951.064.07

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
65.35-24.49-95.7872.4
Long-Term Debt Repaid
-2.56-1.86----
Net Long-Term Debt Issued (Repaid)
62.78-1.8624.49-95.7872.4
Issuance of Common Stock
2.7141.77170.13116.931.510.06
Net Common Stock Issued (Repurchased)
2.7141.77170.13116.931.510.06
Other Financing Activities
-----0.16-0.14
Financing Cash Flow
105.2939.92194.62116.9397.1372.32

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-13.53-60.9777.2439.610.64-8.5

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-159.14-162.73-97.06-76.57-87.81-85.64
Free Cash Flow Growth
------
FCF Margin
-84.32%-148.22%-107.37%-92.57%-136.45%-178.27%
Free Cash Flow Per Share
-3.22-3.38-2.26-2.66-3.85-3.83
Levered Free Cash Flow
-48.66-168.36-91.7-94.66-17.76-47.01
Unlevered Free Cash Flow
-80.14-137.94-88.31-60.56-84.08-102.1
SEC Filings: 10-K · 10-Q